The expanding demand for specific immunological investigation and therapeutic development has spurred significant advances in recombinant growth factor production. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique biological roles, are frequently manufactured using various expression platforms, including bacterial hosts, higher cell cultures, an